{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:22:28Z","timestamp":1773076948103,"version":"3.50.1"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The purpose of this study was to describe the nonlinear pharmacokinetics of piperacillin observed during intermittent infusion and continuous infusion by using a nonparametric population modeling approach. Data were 120 serum piperacillin concentration measurements from eight adult cystic fibrosis (CF) patients. Individual pharmacokinetic parameter estimates during intermittent infusion or continuous infusion were calculated by noncompartmental analysis and with a maximum iterative two-stage Bayesian estimator. To simultaneously describe concentration-time data during intermittent infusion and continuous infusion, nonlinear models were parameterized as two-compartment Michaelis-Menten models. Models were fit to the data with the nonparametric expectation maximization algorithm. The calculations were executed on a remote supercomputer. Nonlinear models were evaluated by log-likelihood estimates, residual plots, and\n            <jats:italic>R<\/jats:italic>\n            <jats:sup>2<\/jats:sup>\n            values, and predictive performance was based on bias (mean weighted error [MWE]) and precision (mean weighted square error [MWSE]). A linear pharmacokinetic model could not describe combined intermittent infusion and continuous infusion data well. A good population model fit to the intermittent infusion and continuous infusion data was obtained with the constructed nonlinear models. Maximum a posteriori probability (MAP) Bayesian\n            <jats:italic>R<\/jats:italic>\n            <jats:sup>2<\/jats:sup>\n            values for the nonlinear models were 0.96 to 0.97. Median parameter estimates for the best nonlinear model were as follows:\n            <jats:italic>\n              K\n              <jats:sub>m<\/jats:sub>\n            <\/jats:italic>\n            , 58 \u00b1 75 mg\/liter (mean and standard deviation);\n            <jats:italic>V<\/jats:italic>\n            <jats:sub>max<\/jats:sub>\n            , 1,904 \u00b1 1,009 mg\/h; volume of distribution of the central compartment, 14.1 \u00b1 3.0 liters;\n            <jats:italic>k<\/jats:italic>\n            <jats:sub>12<\/jats:sub>\n            , 0.63 \u00b1 0.41 h\n            <jats:sup>\u22121<\/jats:sup>\n            ; and\n            <jats:italic>k<\/jats:italic>\n            <jats:sub>21<\/jats:sub>\n            , 0.37 \u00b1 0.19 h\n            <jats:sup>\u22121<\/jats:sup>\n            . The median bias (MWE) and precision (MWSE) values for MAP Bayesian estimation with the Michaelis-Menten model were 0.05 and 4.6 mg\/liters, respectively. The developed nonlinear pharmacokinetic models can be used to optimize piperacillin therapy administered via continuous infusion in patients with CF and have distinct advantages over conventional linear models.\n          <\/jats:p>","DOI":"10.1128\/aac.47.2.541-547.2003","type":"journal-article","created":{"date-parts":[[2003,1,23]],"date-time":"2003-01-23T21:05:59Z","timestamp":1043355959000},"page":"541-547","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["Population Pharmacokinetic Analysis of Nonlinear Behavior of Piperacillin during Intermittent or Continuous Infusion in Patients with Cystic Fibrosis"],"prefix":"10.1128","volume":"47","author":[{"given":"Alexander A.","family":"Vinks","sequence":"first","affiliation":[{"name":"Division of Pharmacology Research and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.","family":"den Hollander","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley E.","family":"Overbeek","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger W.","family":"Jelliffe","sequence":"additional","affiliation":[{"name":"Laboratory of Applied Pharmacokinetics, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan W.","family":"Mouton","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen"},{"name":"Department of Clinical Microbiology and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.6.1465"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197926141"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238070"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2165\/00003495-199447030-00008","volume":"47","year":"1994","unstructured":"Bryson, H. M., and R. N. Brogden. 1994. Piperacillin\/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs47:506-535.","journal-title":"Drugs"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.12.2577"},{"key":"e_1_3_2_7_2","first-page":"1065","volume":"17","year":"1916","unstructured":"DuBois, D., and E. F. DuBois. 1916. A formula to estimate the appropriate surface area if height and weight are known. Arch. Intern. Med.17:1065-1072.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01163.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92283-5"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007691-199310000-00005","volume":"15","year":"1993","unstructured":"Jelliffe, R. W., A. Schumitzky, M. Van Guilder, M. Liu, L. Hu, P. Maire, P. Gomis, X. Barbaut, and B. Tahani. 1993. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Ther. Drug Monit.15:380-393.","journal-title":"Ther. Drug Monit."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-4347(93)80369-F","volume":"612","year":"1993","unstructured":"Kucharczyk, N. 1993. Estimation of the lower limit of quantitation, a method detection performance parameter for biomedical assays, from calibration curves. J. Chromatogr.612:71-76.","journal-title":"J. Chromatogr."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199120060-00001","volume":"20","year":"1991","unstructured":"Ludden, T. M. 1991. Nonlinear pharmacokinetics: clinical implications. Clin. Pharmacokinet.20:429-446.","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950040403"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-4825(92)90011-B"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2817"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950030212"},{"key":"e_1_3_2_17_2","first-page":"141","volume":"45","year":"1991","unstructured":"Schumitzky, A. 1991. Nonparametric EM algorithms for estimating prior distributions. Appl. Math. Comput.45:141-157.","journal-title":"Appl. Math. Comput."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01060893"},{"key":"e_1_3_2_19_2","first-page":"39","volume":"31","year":"1993","unstructured":"Sorgel, F., and M. Kinzig. 1993. The chemistry, pharmacokinetics and tissue distribution of piperacillin\/tazobactam. J. Antimicrob. Chemother.31(Suppl. A):39-60.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.6.829"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008634911114"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199610000-00007"},{"key":"e_1_3_2_23_2","first-page":"1229","volume":"46","year":"1992","unstructured":"Van der Vaart, F. J. 1992. Guidelines for validation of analytical procedures in pharmaceutical and biopharmaceutical analyis. Pharm. Weekbl.46:1229-1235.","journal-title":"Pharm. Weekbl."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.1.125"},{"key":"e_1_3_2_25_2","first-page":"89","volume":"10","year":"1999","unstructured":"Vinks, A. A., J. W. Mouton, H. G. M. Heijerman, and W. Bakker. 1999. Pharmacodynamic and pharmacokinetic optimisation of treatment with \u03b2-lactam antibiotics in cystic fibrosis. Rev. Med. Microbiol.10:89-107.","journal-title":"Rev. Med. Microbiol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/clpt.1993.150","volume":"54","year":"1993","unstructured":"Wang, J. P., J. D. Unadkat, S. M. al-Habet, T. A. O'Sullivan, J. Williams-Warren, A. L. Smith, and B. Ramsey. 1993. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin. Clin. Pharmacol. Ther.54:293-302.","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0306-9877(98)90070-6","volume":"51","year":"1998","unstructured":"Woodland, C., D. Blowey, S. Ito, M. Spino, and G. Koren. 1998. Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosis. Med. Hypotheses51:489-491.","journal-title":"Med. Hypotheses"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2460-2467.2001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Yamaoka K. T. Nakagawa and T. Uno. 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6 : 165-175.","DOI":"10.1007\/BF01117450"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.2.541-547.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.2.541-547.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:51:59Z","timestamp":1645465919000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.2.541-547.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1128\/AAC.47.2.541-547.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.2.541-547.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"2001-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-10-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}